With the Northern Hemisphere moving fully into winter mode, industry observers and health professionals alike are forecasting a particularly challenging cold and flu season, with implications for consumer behaviour, product demand and nutraceutical innovation.
Against this backdrop, supplement providers are stepping forward with targeted formulations that have been designed to support respiratory health, immune function and general well-being during the colder months.
Public health commentary suggests that this year’s influenza season may be more severe than usual, driven by viral mutations and increased transmissibility.
Reports from global health sectors indicate rising viral activity earlier in the season and, in some regions (such as the UK), hospitals are preparing for substantial pressure from flu cases.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Nutraceutical Business Review.
Subscribe now Already a subscriber? Sign in here.